Sökning: WFRF:(Helland A) >
PCM4EU and PRIME-RO...
PCM4EU and PRIME-ROSE : Collaboration for implementation of precision cancer medicine in Europe
-
- Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar (författare)
- Leiden University Medical Center
-
- Taskén, Kjetil (författare)
- Oslo University Hospital
-
- F Haj Mohammad, Soemeya (författare)
- Leiden University Medical Center
-
visa fler...
-
- Fagereng, Gro Live (författare)
- Oslo University Hospital
-
- Sørum Falk, Ragnhild (författare)
- Oslo University Hospital
-
- Helland, Åslaug (författare)
- Oslo University Hospital
-
- Jalkanen, Katriina (författare)
- Helsinki University Hospital
-
- Edsjö, Anders (författare)
- Skåne University Hospital
-
- Russnes, Hege G (författare)
- Oslo University Hospital
-
- Steen Carlsson, Katarina (författare)
- Swedish Institute for Health Economics
-
- Ryll, Bettina (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Lassen, Ulrik (författare)
- Copenhagen University Hospital
-
- Hallersjö Hult, Ebba (författare)
- Stockholm School of Economics,Handelshögskolan i Stockholm
-
- Lugowska, Iwona (författare)
- Maria Curie-Skłodowska University
-
- Blay, Jean-Yves (författare)
- Centre Léon Bérard
-
- Verlingue, Loic (författare)
- Centre Léon Bérard
-
- Abel, Edvard (författare)
- University of Gothenburg
-
- Lowery, Maeve A (författare)
- Trinity College Dublin
-
- Krebs, Matthew G (författare)
- The Christie NHS Foundation Trust
-
- Staal Rohrberg, Kristoffer (författare)
- Copenhagen University Hospital
-
- Ojamaa, Kristiina (författare)
- Tartu University Hospital
-
- Oliveira, Julio (författare)
- IPO Porto
-
- Verheul, Henk M W (författare)
- Erasmus MC Cancer Institute
-
- Voest, Emile E (författare)
- The Netherlands Cancer Institute (The Netherlands, Amsterdam) - NKI-AVL
-
- Gelderblom, Hans (författare)
- Leiden University Medical Center
-
visa färre...
-
(creator_code:org_t)
-
- 2024
- 2024
- Engelska.
-
Ingår i: Acta Oncologica. - 1651-226X .- 1651-226X. ; 63, s. 385-391
- Relaterad länk:
-
https://research.hhs... (primary) (Object in context)
-
visa fler...
-
https://research.hhs...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: In the two European Union (EU)-funded projects, PCM4EU (Personalized Cancer Medicine for all EU citizens) and PRIME-ROSE (Precision Cancer Medicine Repurposing System Using Pragmatic Clinical Trials), we aim to facilitate implementation of precision cancer medicine (PCM) in Europe by leveraging the experience from ongoing national initiatives that have already been particularly successful. PATIENTS AND METHODS: PCM4EU and PRIME-ROSE gather 17 and 24 partners, respectively, from 19 European countries. The projects are based on a network of Drug Rediscovery Protocol (DRUP)-like clinical trials that are currently ongoing or soon to start in 11 different countries, and with more trials expected to be established soon. The main aims of both the projects are to improve implementation pathways from molecular diagnostics to treatment, and reimbursement of diagnostics and tumour-tailored therapies to provide examples of best practices for PCM in Europe. RESULTS: PCM4EU and PRIME-ROSE were launched in January and July 2023, respectively. Educational materials, including a podcast series, are already available from the PCM4EU website (http://www.pcm4eu.eu). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in 2024. CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients. ble from the PCM4EU website (http://www.pcm4eu.eu). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in 2024. CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Barjesteh van Wa ...
-
Taskén, Kjetil
-
F Haj Mohammad, ...
-
Fagereng, Gro Li ...
-
Sørum Falk, Ragn ...
-
Helland, Åslaug
-
visa fler...
-
Jalkanen, Katrii ...
-
Edsjö, Anders
-
Russnes, Hege G
-
Steen Carlsson, ...
-
Ryll, Bettina
-
Lassen, Ulrik
-
Hallersjö Hult, ...
-
Lugowska, Iwona
-
Blay, Jean-Yves
-
Verlingue, Loic
-
Abel, Edvard
-
Lowery, Maeve A
-
Krebs, Matthew G
-
Staal Rohrberg, ...
-
Ojamaa, Kristiin ...
-
Oliveira, Julio
-
Verheul, Henk M ...
-
Voest, Emile E
-
Gelderblom, Hans
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Hälso och sjukvå ...
- Artiklar i publikationen
-
Acta Oncologica
- Av lärosätet
-
Handelshögskolan i Stockholm